bluebird bio Inc (BLUE)

74.99 +0.00  +0.00% NASDAQ Nov 18, 16:01 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/21/2020 Earnings Bluebird Bio Inc Fourth Quarter Earnings Results in 2019
10/31/2019 Earnings Bluebird Bio Inc Third Quarter Earnings Results for 2019
08/01/2019 Earnings Bluebird Bio Inc Second Quarter Earnings Results in 2019
06/06/2019 12:00 EDT Misc Bluebird Bio Inc Annual General Meeting in 2018
05/02/2019 Earnings Bluebird Bio Inc First Quarter Earnings Results in 2019
02/21/2019 Earnings Bluebird Bio Inc Fourth Quarter Earnings Results in 2018
02/21/2019 Misc Bluebird Bio Inc Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.bluebirdbio.com
  • Investor Relations URL: http://investor.bluebirdbio.com/phoenix.zhtml?c=251820&p=irol-irhome
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 21, 2020
  • Last Earnings Release: Oct. 31, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Bluebird Bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.

Top Fund Holders

Symbol Name Weighting
IDNA iShares Genomics Immnlgy & Hlthcr ETF 2.71%
CNCR Loncar Cancer Immunotherapy ETF 2.28%
FIJYX Fidelity Advisor® Biotechnology Z 2.16%
USTCX USAA Science & Technology Adviser 1.71%
ATL1735 Renaissance Global Health Care Class O 1.47%
RSEKX Victory RS Small Cap Growth R 1.36%
BTEC Principal Healthcare Innovators ETF 1.31%
FBIOX Fidelity® Select Biotechnology 1.21%
HQL Tekla Life Sciences Investors 1.05%
FVUSA00146 AST Small Cap Growth Opportunities 0.93%
HQH Tekla Healthcare Investors 0.90%
BBH VanEck Vectors Biotech ETF 0.50%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.